Skip to content
★ Sign in to follow
TW

Torbjörn Wärnheim

Moberg Pharma AB
Total declarations
6
Company
1
▲ Purchases (3 ops.)
€43k
▼ Sales (1 ops.)
€47k

Latest filing published 24 Nov 2019 for Moberg Pharma AB, €29k.

Filing timeline

BuySale
Torbjörn Wärnheim

Insider track record

Disclosed buys
3
Disclosed sells
1
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Torbjörn Wärnheim: trading record in brief

This profile gathers the share dealings of Torbjörn Wärnheim in Moberg Pharma AB. The record holds 6 filings, for trades running from 9 March 2018 to 22 November 2019.

Both buying and selling appear: 3 purchases worth €43k, against 1 sale worth €47k. On balance, insiders were net sellers of €4,012. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. In 2019 alone, the filings show 1 purchase and 1 sale.

The median purchase comes to €9,318.

On 24 November 2019 came the latest disclosure, a transaction for €29k in Moberg Pharma AB. The most recent open-market purchase was published on 1 July 2019, 2,687 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Torbjörn Wärnheim

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ●
    SVP R&DExecutivesMoberg Pharma AB
    308,528 SEK13FI-SE
    6,635 shares@ SEK 46.5022.4% of flowInlösenaktieISIN SE0013121365FI:csv-95fe06a146dcbacd8ae5
  • ▲
    SVP R&DExecutivesMoberg Pharma AB
    322,275 SEK0FI-SE
    7,500 shares@ SEK 42.9723.6% of flowAktieISIN SE0003613090FI:csv-94fe9e56e89f80cd3ec4
    Canonical exit: 26 Sept 2019 (T+90)
  • ▼
    SVP R&DExecutivesMoberg Pharma AB
    500,042 SEK30FI-SE
    7,500 shares@ SEK 66.672236.6% of flowAktieISIN SE0003613090FI:csv-22f2ab1c0f3dbf3f7e85
  • ◆
    SVP R&DExecutivesMoberg Pharma AB
    142,618 SEK12FI-SE
    2,135 shares@ SEK 66.8010.2% of flowAktieISIN SE0003613090FI:csv-cfd3b1cc70d0744ef4ba
  • ▲
    VP Pharm DevExecutivesMoberg Pharma AB
    97,350 SEK12FI-SE
    3,000 shares@ SEK 32.457.2% of flowISIN SE0003613090FI:csv-a5dee0e2abffd917b3b5
    Canonical exit: 27 Sept 2018 (T+90)
  • ▲
    Director Pharmaceutical Innovation DevelopmentExecutivesMoberg Pharma AB
    35,850 SEK34FI-SE
    1,500 shares@ SEK 23.90100.0% of flowISIN SE0003613090FI:csv-e839aabbb722470e6b82
    Canonical exit: 7 Jun 2018 (T+90)

6 of 6 declarations